Replies to post #484722 on Anavex Life Sciences Corp (AVXL)

[boi568]

This appears to be an international patent application, and not a granted patent.

I have not read much more than the first page, but I did notice Figure 1, which a graphical form of the illustration Anavex has been displaying of the parts of the brain that are more or less impacted by blarcamesine during the 48 week 2b/3 trial. (These are the results with the extremely low p value result.)

Please excuse my clumsy editing, but take a look -- the results are pretty astonishing in this format. Keep in mind these are AD patients; a normally aging population will still average about a one percent loss during the 48 week time period.

[Hoskuld]

Nice claims in the patent. However, it is a patent only. Anyone who has filed patents (I have 4 approved) knows the difference between patent claims and probably commercial applications.

Would love to see them run more trials and get clinical proof of claims.

[rx7171]

In the future this patent if approved has massive potential way beyond AD.
If every adult after forty takes a daily Anavex pill even if only $1 a pill the revenue would be astronomical.
Who wouldn’t want a pill to drastically slow their brain from shrinking?

I know I’d be first in line.